Recommended Dosages for Common Stroke Prevention Drugs
Stroke prevention typically involves antiplatelet or anticoagulant drugs for patients with atrial fibrillation (AFib), carotid artery disease, or prior transient ischemic attack (TIA). Dosages vary by drug, patient risk (e.g., CHA2DS2-VASc score for AFib), kidney function, age, and bleeding risk. Always follow prescribing information and physician guidance.[1]
Aspirin for Primary or Secondary Prevention
Aspirin is first-line for non-cardioembolic stroke prevention.
- Low-dose: 81 mg daily (U.S. standard) or 75-100 mg daily (international).
- Higher doses (325 mg) were common but increase bleeding risk without added benefit.[2]
Used alone or with dipyridamole (25 mg aspirin + 200 mg extended-release dipyridamole twice daily).
Anticoagulants for AFib-Related Stroke Risk
Direct oral anticoagulants (DOACs) or warfarin are preferred over aspirin for AFib patients with CHA2DS2-VASc ≥2 (men) or ≥3 (women).
- Apixaban (Eliquis): 5 mg twice daily; reduce to 2.5 mg twice daily if ≥2 of: age ≥80, weight ≤60 kg, creatinine ≥1.5 mg/dL.[3]
- Rivaroxaban (Xarelto): 20 mg once daily with evening meal; 15 mg once daily if CrCl 15-49 mL/min.[4]
- Dabigatran (Pradaxa): 150 mg twice daily; 75 mg twice daily if CrCl 15-30 mL/min (U.S.).[5]
- Edoxaban (Savaysa): 60 mg once daily; 30 mg if CrCl 15-50 mL/min, weight ≤60 kg, or on P-gp inhibitors.[6]
- Warfarin: Dose-adjusted to INR 2-3 (typically 2-10 mg daily).[1]
Dual Antiplatelet Therapy (DAPT) After Recent TIA or Minor Stroke
Short-term for high-risk non-cardioembolic events (within 21 days).
- Aspirin 50-325 mg + clopidogrel 75 mg daily for 21-90 days, then monotherapy.[7]
- Ticagrelor 90 mg twice daily + aspirin 81 mg daily for 30 days (THALES trial).[8]
Clopidogrel Alone
75 mg daily for aspirin-intolerant patients or PAD-related stroke risk.[2]
How Kidney Function Affects Dosing
Creatinine clearance (CrCl) drives DOAC adjustments—avoid most if CrCl <15 mL/min or on dialysis. Warfarin requires frequent INR monitoring.[1][3]
What If a Patient Has Bleeding Risk or Is Elderly?
Use HAS-BLED score to assess. Lower DOAC doses, avoid DAPT beyond 21 days, or switch to left atrial appendage closure for high-risk AFib.[1] Proton pump inhibitors reduce GI bleed risk with antiplatelets.
When to Use Aspirin vs. DOACs
Aspirin for low AFib risk or non-AFib strokes; DOACs reduce stroke 60-70% more than warfarin in trials but cost more.[9] No routine combo of DOAC + antiplatelet except post-stent.
Duration of Therapy
Lifelong for AFib or high-risk cases; reassess annually. Stop DAPT after 21-90 days to minimize bleeds.[7]
Sources
[1]: AHA/ACC Stroke Prevention Guidelines (2024)
[2]: USPSTF Aspirin Recommendations
[3]: Eliquis Prescribing Information
[4]: Xarelto Prescribing Information
[5]: Pradaxa Prescribing Information
[6]: Savaysa Prescribing Information
[7]: POINT Trial (NEJM)
[8]: THALES Trial (NEJM)
[9]: ARISTOTLE Trial (NEJM)